Skip to content

COMPARING THE EFFECT OF EXPOSURE TO INHALED BUDESONIDE VERSUS FLUTICASONE PROPIONATE IN PARTICIPANTS UNDERGOING ELECTIVE INTUBATION ON POST OPERATIVE SORE THROAT, COUGH, AND HOARSENESS OF VOICE

COMPARING THE EFFICACY OF INHALED BUDESONIDE SUSPENSION VERSUS INHALED FLUTICASONE PROPIONATE ADMINISTERED USING A METERED DOSE INHALER, ON POST- OPERATIVE SORE THROAT, HOARSENESS OF VOICE AND COUGH AN OBSERVATIONAL STUDY. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101837
Enrollment
104
Registered
2026-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: INHALED FLUTICASONE PROPIONATE MDI: COMPARING THE EFFICASY ON POST ENDOTRACHEAL INTUBATION ON POST OPERATIVE SORE THROAT, HOARSENESS OF VOICE AND COUGH Control Intervention1: INHALED BU

Sponsors

DrRinka Pal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I (healthy patients) and II (mild to moderate systemic disease but medically well controlled). Patients posted for elective surgeries in Operation theater. Patients who are MPC 1(complete visualization of uvula)) or 2 (uvula partly visible) as assessed by a senior anesthetist.

Exclusion criteria

Exclusion criteria: Patients with known allergy to corticosteroid. Patients who are not willing to participate in this study. Patients with pre-existing cardiovascular, renal and hepatic disorders. Patients who have difficult airways as assessed by a senior anesthetist (obese (BMI MORE THAN 30 kg/meter sq), distorted airways. Patients who are anticipated difficult intubation. Patients already on analgesic or steroids (systemic or inhaled). Patients with pre-operative sore throat.

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE EFFECTIVENESS OF INHALED BUDESONIDE SUSPENSION VERSUS INHALED FLUTICASONE PROPIONATE (ADMINISTERED VIA METERED-DOSE INHALER) IN REDUCING THE INCIDENCE AND SEVERITY OF POST-OPERATIVE SORE THROAT (POST).Timepoint: ASSESSED AT BASELINE (POST EXTUBATION), 2HOURS, 4 HOURS, 6 HOURS, 12HOURS, AND AT 24 HOURS

Secondary

MeasureTime frame
TO EVALUATE THE EFFECT OF INHALED BUDESONIDE AND INHALED FLUTICASONE PROPIONATE ON THE HEMODYNAMIC CHANGESTimepoint: ASSESSED AT BASELINE AFTER INDUCTION, POST INDUCTION, 15 MINUTES, 30 MINUTES, 45 MINUTES, 60 MINUTES, 90 MINUTES,120 MINUTES, BEFORE EXTUBATION, IMMEDIATELY POST EXTUBATION.

Countries

India

Contacts

Public ContactDr Sukriti Atram

Grant Government Medical college and Sir J J Hospital.

sukritiatram@yahoo.co.in9004083034

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026